lobbying_activities: 3051491

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3051491	cbe61bd7-acaa-4d6e-96d7-05facde9ead9	Q3	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2023	third_quarter	MED	AACC/ADLM wrote and met with the Office of Management and Budget to raise concerns about advancing a proposed rule [Docket No. FDA-2023-N-2177], which would extend the authority of the Food and Drug Administration to regulate laboratory developed tests.	Office of Management & Budget (OMB)		70000	0	0	2023-10-16T15:49:13-04:00